SUZHOU, China, July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US FDA-approved registrational clinical trial. This Phase I China registrational clinical trial for XS228 Cell Injection – the world's first "off-the-shelf", allogeneic, iPSC-derived, spinal neural progenitor cell therapy targeting major neurological...
LOS ANGELES, Jan. 14, 2025 /PRNewswire/ -- Triller, a creator-focused social media platform, has jumped more than 100 spots on the Apple App download...
DataMan 290 and 390 barcode readers, backed by industry-leading customer support, deliver unmatched reliability and ease of use
NATICK, Mass., Jan. 14, 2025 /PRNewswire/ --...
GUANGZHOU, China, Jan. 14, 2025 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value...
DUBAI, UAE, Jan. 14, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is excited to announce its partnership with Entravel,...